CRDF icon

Cardiff Oncology
CRDF

Overview Fund Activity

48 hedge funds and large institutions have $3.84M invested in Cardiff Oncology in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 9 closing their positions.

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
12
Closed
9
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$5K

Top Buyers

1
SM
1
Sabby Management
Florida
$1.23M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$620K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$357K
4
EP
4
Elkhorn Partners
Nebraska
$212K
5
VF
5
Virtu Financial
New York
$58K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$11K
2
ECM
2
Element Capital Management
New York
$0
3
LP
3
LMR Partners
United Kingdom
$0
4
PP
4
Paloma Partners
Connecticut
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$8K
Name Market Value Shares Shares
Change 		Shares
Change %
Creative Planning
51
Creative Planning
Kansas
– – -7,500 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– – -5,305 Closed
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– – -1,241 Closed
Wells Fargo
54
Wells Fargo
California
– – -835 Closed
CG
55
Cutler Group
California
$0 700 -400 -36%
Deutsche Bank
56
Deutsche Bank
Germany
$0 371 – –
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$0 220 +20 +10%
1 2
3